The effect of anti-tumour necrosis factor alpha treatment on the antibody response to influenza vaccination. [electronic resource]
Producer: 20081114Description: 713-6 p. digitalISSN:- 1468-2060
- Adalimumab
- Adult
- Aged
- Antibodies, Monoclonal -- therapeutic use
- Antibodies, Monoclonal, Humanized
- Antibodies, Viral -- blood
- Arthritis, Rheumatoid -- drug therapy
- Autoimmune Diseases -- drug therapy
- Case-Control Studies
- Crohn Disease -- drug therapy
- Etanercept
- Female
- Hemagglutination Inhibition Tests
- Humans
- Immunoglobulin G -- therapeutic use
- Immunosuppressive Agents -- therapeutic use
- Infliximab
- Influenza A Virus, H3N2 Subtype -- immunology
- Influenza B virus -- immunology
- Influenza Vaccines -- administration & dosage
- Influenza, Human -- immunology
- Male
- Middle Aged
- Receptors, Tumor Necrosis Factor -- therapeutic use
- Time Factors
- Tumor Necrosis Factor-alpha -- antagonists & inhibitors
No physical items for this record
Publication Type: Comparative Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.